Skip to main content
Equibles

AQR CAPITAL MANAGEMENT LLC

Position in TNXP — Tonix Pharmaceuticals Holding Corp.

CIK 1167557 Greenwich, CT
Back to TNXP Full portfolio

Position in TNXP

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$11,261,909
+$9,045,302 QoQ
Shares Held
882,595
+447.5% QoQ
Ownership
5.15%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#4
of 103 holders
Holding Since
Jun 2021
6 quarters on record
Voting authority Sole 98% Shared 0% None 2%

Common Shares in TNXP Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

AQR CAPITAL MANAGEMENT LLC holds $5,658,888,286 across 216 Biotechnology names. TNXP ranks #50 (0.2% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 REGN
Regeneron Pharmaceuticals, Inc.
 1,126,080 $702,155,918
2 INCY
Incyte Corp
 5,320,901 $603,177,333
3 EXEL
Exelixis, Inc.
 11,023,943 $599,812,735
4 JAZZ
Jazz Pharmaceuticals plc
 1,522,568 $366,893,205
5 BMRN
Biomarin Pharmaceutical Inc
 5,699,541 $326,127,732
6 VRTX
Vertex Pharmaceuticals Inc / Ma
 616,170 $306,070,117
7 RVMD
Revolution Medicines, Inc.
 1,295,450 $242,611,869
8 RPRX
Royalty Pharma plc
 4,305,412 $241,404,446

All Filings in TNXP

Export CSV
6 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $11,261,909 882,595
2026-03-31 $2,216,607 161,208
2025-12-31 $312,710 20,020
2021-12-31 $368,825 1,024,514
2021-09-30 $53,509 89,183
2021-06-30 $268,030 241,469